Literature DB >> 22469507

SNP-based arrays complement classic cytogenetics in the detection of chromosomal aberrations in Wilms' tumor.

Reena Zin1, Kym Pham, Murch Ashleigh, David Ravine, Paul Waring, Adrian Charles.   

Abstract

Wilms' tumors have characteristic chromosomal abnormalities, such as the 11p13 deletion, in a subset of cases. This is one of the very few reports comparing single nucleotide polymorphism (SNP) array analysis with conventional karyotyping of Wilms' tumors. A total of 43 frozen tumor samples were analyzed using the Affymetrix Cytogenetics Whole-Genome 2.7M array. The findings from the SNP array analysis were then compared with those from conventional karyotyping. A comparison between SNP array and conventional karyotype findings was possible in 38 of 43 specimens (88.4%). The SNP array and classic cytogenetic results were concordant in 33 of 38 specimens (87%). SNP array analysis was able to support the findings of classic cytogenetics. The SNP array detected regions of loss of heterozygosity (LOH) in 41 of 43 (95%) specimens. However, it did not detect balanced translocations and inversions that were observed by conventional cytogenetics. Our results show that the data generated from these platforms are complementary. The SNP array also detected additional gains and losses as well as regions of LOH with associated disomy, which are likely to represent segmental uniparental disomy. The observed discrepancies can be explained by the inherent limitations of each technique.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22469507     DOI: 10.1016/j.cancergen.2011.12.003

Source DB:  PubMed          Journal:  Cancer Genet


  5 in total

1.  Array CGH Analysis of Paired Blood and Tumor Samples from Patients with Sporadic Wilms Tumor.

Authors:  Leila Cabral de Almeida Cardoso; Lara Rodriguez-Laguna; María Del Carmen Crespo; Elena Vallespín; María Palomares-Bralo; Rubén Martin-Arenas; Inmaculada Rueda-Arenas; Paulo Antonio Silvestre de Faria; Purificación García-Miguel; Pablo Lapunzina; Fernando Regla Vargas; Hector N Seuanez; Víctor Martínez-Glez
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

2.  Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response.

Authors:  Yogesh Kumar; Jianfeng Yang; Taobo Hu; Lei Chen; Zhi Xu; Lin Xu; Xiao-Xia Hu; Gusheng Tang; Jian-Min Wang; Yi Li; Wai-Sang Poon; Weiqing Wan; Liwei Zhang; Wai-Kin Mat; Frank W Pun; Peggy Lee; Timothy H Y Cheong; Xiaofan Ding; Siu-Kin Ng; Shui-Ying Tsang; Jin-Fei Chen; Peng Zhang; Shao Li; Hong-Yang Wang; Hong Xue
Journal:  BMC Med Genomics       Date:  2015-07-25       Impact factor: 3.063

3.  Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors.

Authors:  A C V Krepischi; M Maschietto; E N Ferreira; A G Silva; S S Costa; I W da Cunha; B D F Barros; P E Grundy; C Rosenberg; D M Carraro
Journal:  Mol Cytogenet       Date:  2016-02-24       Impact factor: 2.009

Review 4.  Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review.

Authors:  Changkai Deng; Rong Dai; Xuliang Li; Feng Liu
Journal:  Cancer Sci       Date:  2016-03-18       Impact factor: 6.716

5.  Association between PHOX2B gene rs28647582 T>C polymorphism and Wilms tumor susceptibility.

Authors:  Ao Lin; Wen Fu; Wenwen Wang; Jinhong Zhu; Jiabin Liu; Huimin Xia; Guochang Liu; Jing He
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.